Insiders · Profile

Willard Stephen H

CHIEF EXECUTIVE OFFICER at NRX Pharmaceuticals. Filing since 16 Dec 2022. CIK 0001325232

Company
Date
Role
Action
Shares
Amount
Of holding
16 Dec 2022
CHIEF EXECUTIVE OFFICER
Bought
50,000
$58.50K
opened
1 decision on file.